Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

A Comprehensive Guide to Choosing the Right Biotech Consultant in California

Jun 25, 2026By Sreejith Kanhirangadan

SK

Understanding the Role of a Biotech Consultant

In the dynamic world of biotechnology, having the right expertise can make all the difference. Biotech consultants play a crucial role in guiding companies through the complexities of the industry. They offer insights into regulatory compliance, market trends, and strategic planning. Hiring the right consultant can accelerate your business growth and ensure that you’re making informed decisions.

Biotech consultants often have specialized knowledge in areas such as drug development, regulatory affairs, and market analysis. Their expertise allows companies to navigate the regulatory landscape and optimize their research and development efforts. Understanding their role is the first step in selecting the right consultant for your needs.

biotech consultant

Identifying Your Needs

Before embarking on the search for a consultant, it's essential to clearly define your company's needs. Are you looking for assistance with regulatory submissions, market entry strategies, or R&D optimization? By pinpointing your specific requirements, you can narrow down the types of consultants who will best suit your needs.

Consider the size and scope of your project. Some consultants specialize in niche areas, while others offer broader services. Understanding what you need will help you identify consultants with the right expertise and experience to guide your business effectively.

Evaluating Experience and Expertise

When choosing a biotech consultant, experience is a key factor. Look for a consultant with a proven track record in your specific area of interest. Consider their years of experience, past projects, and any relevant industry certifications. A consultant with in-depth knowledge of the California biotech landscape can provide valuable insights and connections.

biotech experience

It’s also beneficial to evaluate their expertise in dealing with regulatory bodies such as the FDA. Consultants who are well-versed in regulatory affairs can help streamline the approval process for new products, saving you time and resources.

Checking References and Reviews

One of the best ways to assess a consultant’s capabilities is by checking references and reviews from previous clients. Reach out to companies that have worked with the consultant and inquire about their experiences. Ask about the consultant's communication style, problem-solving abilities, and overall effectiveness.

Online reviews and testimonials can also provide insights into a consultant’s reputation. Look for patterns in client feedback to identify any recurring issues or strengths.

client feedback

Considering Cost and Contracts

Cost is an important consideration when hiring a biotech consultant. While it may be tempting to choose the lowest bid, it’s crucial to weigh the potential return on investment. A more experienced consultant may charge higher fees but could offer invaluable expertise that leads to greater long-term success.

Discuss contract terms in detail, including project scope, timelines, and deliverables. Ensure that all expectations are clearly outlined to avoid any misunderstandings. A well-structured contract can help establish a successful working relationship.

Making the Final Decision

After thorough evaluation and consideration, it’s time to make your decision. Choose a consultant who not only meets your technical requirements but also aligns with your company’s values and culture. A strong partnership can lead to significant advancements and achievements in the biotech field.

Remember, the right consultant can become a valuable asset, driving your company's innovation and success in the ever-evolving biotech industry. Take the time to choose wisely, and your investment will pay off in the long run.